• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

CLSDF previously highlighted Source MDx, read the post (here)…there is nothing hotter than incorporating validated biomarkers under the umbrella of personalized medicine and that is what continues to transpire at the Source MDx Boulder headquarters. An impressive list of partners and clients of Source MDx include Abbott Labs (NYSE: ABT), Amgen (NASDAQ: AMGN), Celgene (NASDAQ: [...]

No doubt about it Colorado is, to borrow poorly from Billy Joel, an RNA State of Mind. What with the Nobel Prize winning work of Tom Cech for the discovery of catalytic properties of RNA, to the work being done at Sirna now Merck (NYSE: MRK) where RNAi technology is being used to develop a [...]

  

to top of page...


 
  • The Latest LSDF Activity

    May 2012
    M T W T F S S
    « Oct    
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com